Linked Life Data

18217912

Source:http://linkedlifedata.com/resource/pubmed/id/18217912

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-1-25
pubmed:abstractText
Transplant patients are at increased risk of developing dyslipidemia, which contributes to coronary artery disease and cardiovascular events. The purpose of this study was to explore documented adverse effects of liver transplant recipients receiving lipid-lowering therapies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1399-0012
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-9
pubmed:meshHeading
pubmed:articleTitle
Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.
pubmed:affiliation
College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA.
pubmed:publicationType
Journal Article